ClinicalTrials.gov record
A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol
ClinicalTrials.gov ID: NCT00138762
Public ClinicalTrials.gov record NCT00138762. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced Apr 24, 2026, 12:10 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orally Once Daily for 6 Months, Compared to Atorvastatin Alone or Placebo in Subjects With Mixed Dyslipidemia (Fredrickson Types IIa and IIb).
Study identification
- NCT ID
- NCT00138762
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 3,800 participants
Conditions and interventions
Conditions
Interventions
- atorvastatin Drug
- placebo Drug
- torcetrapib/atorvastatin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2004
- Primary completion
- Jul 31, 2006
- Completion
- Jul 31, 2006
- Last update posted
- Feb 16, 2012
2004 – 2006
United States locations
- U.S. sites
- 96
- U.S. states
- 33
- U.S. cities
- 96
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Mobile | Alabama | — | — |
| Pfizer Investigational Site | Mesa | Arizona | — | — |
| Pfizer Investigational Site | Oro Valley | Arizona | — | — |
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Sun City | Arizona | — | — |
| Pfizer Investigational Site | Little Rock | Arkansas | — | — |
| Pfizer Investigational Site | Anaheim | California | — | — |
| Pfizer Investigational Site | Carmichael | California | — | — |
| Pfizer Investigational Site | Concord | California | — | — |
| Pfizer Investigational Site | Greenbrae | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Mission Viejo | California | — | — |
| Pfizer Investigational Site | Sacramento | California | — | — |
| Pfizer Investigational Site | Santa Ana | California | — | — |
| Pfizer Investigational Site | Stockton | California | — | — |
| Pfizer Investigational Site | Thouasand Oaks | California | — | — |
| Pfizer Investigational Site | Tustin | California | — | — |
| Pfizer Investigational Site | Upland | California | — | — |
| Pfizer Investigational Site | Walnut Creek | California | — | — |
| Pfizer Investigational Site | Westlake Village | California | — | — |
| Pfizer Investigational Site | Boulder | Colorado | — | — |
| Pfizer Investigational Site | Waterbury | Connecticut | — | — |
| Pfizer Investigational Site | Newark | Delaware | — | — |
| Pfizer Investigational Site | Coral Gables | Florida | — | — |
| Pfizer Investigational Site | Ft. Pierce | Florida | — | — |
| Pfizer Investigational Site | Jacksonville | Florida | — | — |
| Pfizer Investigational Site | Jupiter | Florida | — | — |
| Pfizer Investigational Site | Lake Worth | Florida | — | — |
| Pfizer Investigational Site | Melbourne | Florida | — | — |
| Pfizer Investigational Site | Palm Bay | Florida | — | — |
| Pfizer Investigational Site | Sebastian | Florida | — | — |
| Pfizer Investigational Site | Stuart | Florida | — | — |
| Pfizer Investigational Site | Vero Beach | Florida | — | — |
| Pfizer Investigational Site | Wellington | Florida | — | — |
| Pfizer Investigational Site | West Palm Beach | Florida | — | — |
| Pfizer Investigational Site | Chicago | Illinois | — | — |
| Pfizer Investigational Site | Creve Coevr | Illinois | — | — |
| Pfizer Investigational Site | Peoria | Illinois | — | — |
| Pfizer Investigational Site | Rockford | Illinois | — | — |
| Pfizer Investigational Site | Iowa City | Iowa | — | — |
| Pfizer Investigational Site | Kansas City | Kansas | — | — |
| Pfizer Investigational Site | Overland Park | Kansas | — | — |
| Pfizer Investigational Site | Wichita | Kansas | — | — |
| Pfizer Investigational Site | Erlanger | Kentucky | — | — |
| Pfizer Investigational Site | Louisville | Kentucky | — | — |
| Pfizer Investigational Site | Covington | Louisiana | — | — |
| Pfizer Investigational Site | Slidell | Louisiana | — | — |
| Pfizer Investigational Site | Scarborough | Maine | — | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Bethesda | Maryland | — | — |
| Pfizer Investigational Site | Elkton | Maryland | — | — |
| Pfizer Investigational Site | Jackson | Mississippi | — | — |
| Pfizer Investigational Site | Jefferson City | Missouri | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | Billings | Montana | — | — |
| Pfizer Investigational Site | Lincoln | Nebraska | — | — |
| Pfizer Investigational Site | Omaha | Nebraska | — | — |
| Pfizer Investigational Site | Las Vegas | Nevada | — | — |
| Pfizer Investigational Site | Endwell | New York | — | — |
| Pfizer Investigational Site | Lake Success | New York | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Williamsville | New York | — | — |
| Pfizer Investigational Site | Charlotte | North Carolina | — | — |
| Pfizer Investigational Site | Concord | North Carolina | — | — |
| Pfizer Investigational Site | Fayetteville | North Carolina | — | — |
| Pfizer Investigational Site | Monroe | North Carolina | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Elyria | Ohio | — | — |
| Pfizer Investigational Site | Olmsted | Ohio | — | — |
| Pfizer Investigational Site | Westlake | Ohio | — | — |
| Pfizer Investigational Site | Tulsa | Oklahoma | — | — |
| Pfizer Investigational Site | Beaverton | Oregon | — | — |
| Pfizer Investigational Site | Hillsboro | Oregon | — | — |
| Pfizer Investigational Site | Portland | Oregon | — | — |
| Pfizer Investigational Site | Warwick | Rhode Island | — | — |
| Pfizer Investigational Site | Greer | South Carolina | — | — |
| Pfizer Investigational Site | Spartanburg | South Carolina | — | — |
| Pfizer Investigational Site | Kingsport | Tennessee | — | — |
| Pfizer Investigational Site | Nashville | Tennessee | — | — |
| Pfizer Investigational Site | Austin | Texas | — | — |
| Pfizer Investigational Site | Beaumont | Texas | — | — |
| Pfizer Investigational Site | Bryan | Texas | — | — |
| Pfizer Investigational Site | Dallas | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | The Colony | Texas | — | — |
| Pfizer Investigational Site | Salt Lake City | Utah | — | — |
| Pfizer Investigational Site | Newport News | Virginia | — | — |
| Pfizer Investigational Site | Norfolk | Virginia | — | — |
| Pfizer Investigational Site | Richmond | Virginia | — | — |
| Pfizer Investigational Site | Renton | Washington | — | — |
| Pfizer Investigational Site | Yakima | Washington | — | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | — | — |
| Pfizer Investigational Site | Oregon | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00138762, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2012 · Synced Apr 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00138762 live on ClinicalTrials.gov.